{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:26:23Z","timestamp":1787037983896,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02462-0","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:51:01Z","timestamp":1786528261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential analysis of gut microbiota and metabolites in patients with Graves\u2019 disease and combined Helicobacter pylori infection"],"prefix":"10.1186","volume":"26","author":[{"given":"Suna","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baokun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"5","key":"2462_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301\u201316. https:\/\/doi.org\/10.1038\/nrendo.2018.18.","journal-title":"Nat Rev Endocrinol"},{"issue":"23","key":"2462_CR2","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1001\/jama.2015.16535","volume":"314","author":"HB Burch","year":"2015","unstructured":"Burch HB, Cooper DS. Management of graves disease: a review. JAMA. 2015;314(23):2544\u201354. https:\/\/doi.org\/10.1001\/jama.2015.16535.","journal-title":"JAMA"},{"issue":"1","key":"2462_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","volume":"6","author":"TF Davies","year":"2020","unstructured":"Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, et al. Graves\u2019 disease. Nat Rev Dis Primers. 2020;6(1):52. https:\/\/doi.org\/10.1038\/s41572-020-0184-y.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2462_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1017\/S0029665118001192","volume":"78","author":"MP Rayman","year":"2019","unstructured":"Rayman MP. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc Nutr Soc. 2019;78(1):34\u201344. https:\/\/doi.org\/10.1017\/S0029665118001192.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"2462_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11154-023-09848-8","volume":"25","author":"L Grixti","year":"2024","unstructured":"Grixti L, Lane LC, Pearce SH. The genetics of graves\u2019 disease. Rev Endocr Metab Disord. 2024;25(1):203\u201314. https:\/\/doi.org\/10.1007\/s11154-023-09848-8.","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2462_CR6","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.beem.2021.101506","volume":"35","author":"C Virili","year":"2021","unstructured":"Virili C, Stramazzo I, Centanni M. Gut microbiome and thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab. 2021;35(3):101506. https:\/\/doi.org\/10.1016\/j.beem.2021.101506.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"2462_CR7","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1038\/s41396-021-01016-7","volume":"15","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Hou Q, Huang S, Ou Q, Huo D, V\u00e1zquez-Baeza Y, et al. Compositional and genetic alterations in graves\u2019 disease gut microbiome reveal specific diagnostic biomarkers. Isme Jisme J. 2021;15(11):3399\u2013411. https:\/\/doi.org\/10.1038\/s41396-021-01016-7.","journal-title":"Isme Jisme J"},{"issue":"6","key":"2462_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1523-5378.2010.00802.x","volume":"15","author":"V Bassi","year":"2010","unstructured":"Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and graves\u2019 disease. Helicobacter. 2010;15(6):558\u201362. https:\/\/doi.org\/10.1111\/j.1523-5378.2010.00802.x.","journal-title":"Helicobacter"},{"issue":"5778","key":"2462_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355\u201359. https:\/\/doi.org\/10.1126\/science.1124234.","journal-title":"Science"},{"issue":"8","key":"2462_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895\u2013905. https:\/\/doi.org\/10.1038\/nm.3914.","journal-title":"Nat Med"},{"issue":"1","key":"2462_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/annrheumdis-2019-215743","volume":"79","author":"T Kishikawa","year":"2020","unstructured":"Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, et al. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann Rheumatic Dis. 2020;79(1):103\u201311. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215743.","journal-title":"Ann Rheumatic Dis"},{"issue":"1","key":"2462_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40168-018-0520-6","volume":"6","author":"Z Ye","year":"2018","unstructured":"Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, et al. A metagenomic study of the gut microbiome in Behcet\u2019s disease. Microbiome. 2018;6(1):135. https:\/\/doi.org\/10.1186\/s40168-018-0520-6.","journal-title":"Microbiome"},{"issue":"22","key":"2462_CR13","doi-asserted-by":"publisher","first-page":"8733","DOI":"10.3390\/ijms21228733","volume":"21","author":"A Cano-Ortiz","year":"2020","unstructured":"Cano-Ortiz A, Laborda-Illanes A, Plaza-Andrades I, Membrillo Del Pozo A, Villarrubia Cuadrado A, Rodr\u00edguez Calvo de Mora M, et al. Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary Sj\u00f6gren\u2019s syndrome. IJMS. 2020;21(22):8733. https:\/\/doi.org\/10.3390\/ijms21228733.","journal-title":"IJMS"},{"issue":"19","key":"2462_CR14","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","volume":"185","author":"X Zhou","year":"2022","unstructured":"Zhou X, Baumann R, Gao X, Mendoza M, Singh S, Katz Sand I, et al. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. Cell. 2022;185(19):3467\u201386.e16. https:\/\/doi.org\/10.1016\/j.cell.2022.08.021.","journal-title":"Cell"},{"issue":"7","key":"2462_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","volume":"78","author":"D Azzouz","year":"2019","unstructured":"Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheumatic Dis. 2019;78(7):947\u201356. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214856.","journal-title":"Ann Rheumatic Dis"},{"issue":"9","key":"2462_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353\u201367. https:\/\/doi.org\/10.1136\/gutjnl-2015-309252.","journal-title":"Gut"},{"issue":"1","key":"2462_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou J-M, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. https:\/\/doi.org\/10.1038\/s41572-023-00431-8.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"2462_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1346-8138.2012.01675.x","volume":"39","author":"M El-Khalawany","year":"2012","unstructured":"El-Khalawany M, Mahmoud A, Mosbeh AS, Abd Alsalam F, Ghonaim N, Abou-Bakr A. Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients. J Dermatol. 2012;39(12):989\u201395. https:\/\/doi.org\/10.1111\/j.1346-8138.2012.01675.x.","journal-title":"J Dermatol"},{"issue":"3","key":"2462_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2337\/dc11-1043","volume":"35","author":"CY Jeon","year":"2012","unstructured":"Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012;35(3):520\u201325. https:\/\/doi.org\/10.2337\/dc11-1043.","journal-title":"Diabetes Care"},{"issue":"6","key":"2462_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","volume":"113","author":"R Stasi","year":"2009","unstructured":"Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009;113(6):1231\u201340. https:\/\/doi.org\/10.1182\/blood-2008-07-167155.","journal-title":"Blood"},{"issue":"4","key":"2462_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","volume":"7","author":"OE Okosieme","year":"2019","unstructured":"Okosieme OE, Taylor PN, Evans C, Thayer D, Chai A, Khan I, et al. Primary therapy of Graves\u2019 disease and cardiovascular morbidity and mortality: a linked-record cohort study. Lancet Diabetes Endocrinol. 2019;7(4):278\u201387. https:\/\/doi.org\/10.1016\/S2213-8587(19)30059-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"29","key":"2462_CR22","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala SM, et al. Role of the normal gut microbiota. WJG. 2015;21(29):8787\u2013803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787.","journal-title":"WJG"},{"issue":"9","key":"2462_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.molmed.2020.04.001","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X, Chen BD, Zhao LD, Li H. The gut microbiota: emerging evidence in autoimmune diseases. Trends Mol Med. 2020;26(9):862\u201373. https:\/\/doi.org\/10.1016\/j.molmed.2020.04.001.","journal-title":"Trends Mol Med"},{"key":"2462_CR24","doi-asserted-by":"publisher","first-page":"663131","DOI":"10.3389\/fcimb.2021.663131","volume":"11","author":"SC Chang","year":"2021","unstructured":"Chang SC, Lin SF, Chen ST, Chang P-Y, Yeh Y-M, Lo F-S, et al. Alterations of gut microbiota in patients with graves\u2019 disease. Front Cell Infect Microbiol. 2021;11:663131. https:\/\/doi.org\/10.3389\/fcimb.2021.663131.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"2462_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1089\/thy.2020.0193","volume":"31","author":"W Jiang","year":"2021","unstructured":"Jiang W, Yu X, Kosik RO, Song Y, Qiao T, Tong J, et al. Gut microbiota May play a significant role in the pathogenesis of graves\u2019 disease. Thyroid\u00ae. 2021;31(5):810\u201320. https:\/\/doi.org\/10.1089\/thy.2020.0193.","journal-title":"Thyroid\u00ae"},{"key":"2462_CR26","doi-asserted-by":"publisher","unstructured":"Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011;6(10):e25792. https:\/\/doi.org\/10.1371\/journal.pone.0025792.","DOI":"10.1371\/journal.pone.0025792"},{"issue":"11","key":"2462_CR27","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1210\/clinem\/dgaa511","volume":"105","author":"X Su","year":"2020","unstructured":"Su X, Yin X, Liu Y, Yan X, Zhang S, Wang X, et al. Gut dysbiosis contributes to the imbalance of Treg and Th17 cells in graves\u2019 disease patients by propionic acid. J CLIN ENDOCR Metab. 2020;105(11):3526\u201347. https:\/\/doi.org\/10.1210\/clinem\/dgaa511.","journal-title":"J CLIN ENDOCR Metab"},{"key":"2462_CR28","doi-asserted-by":"publisher","unstructured":"Yan HX, An WC, Chen F, An B, Pan Y, Jin J, et al. Intestinal microbiota changes in graves\u2019 disease: a prospective clinical study. Biosci Rep. 2020;40(9):BSR20191242. https:\/\/doi.org\/10.1042\/BSR20191242.","DOI":"10.1042\/BSR20191242"},{"issue":"9","key":"2462_CR29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s40618-021-01507-6","volume":"44","author":"J Chen","year":"2021","unstructured":"Chen J, Wang W, Guo Z, Huang S, Lei H, Zang P, et al. Associations between gut microbiota and thyroidal function status in Chinese patients with Graves\u2019 disease. J Endocrinol Invest. 2021;44(9):1913\u201326. https:\/\/doi.org\/10.1007\/s40618-021-01507-6.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2462_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","volume":"6","author":"G Masetti","year":"2018","unstructured":"Masetti G, Moshkelgosha S, K\u00f6hling HL, Covelli D, Banga JP, Berchner-Pfannschmidt U, et al. Gut microbiota in experimental murine model of graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease. Microbiome. 2018;6(1):97. https:\/\/doi.org\/10.1186\/s40168-018-0478-4.","journal-title":"Microbiome"},{"issue":"2","key":"2462_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3920\/BM2010.0011","volume":"2","author":"EP Kiseleva","year":"2011","unstructured":"Kiseleva EP, Mikhailopulo KI, Sviridov OV, Novik G, Knirel Y, Szwajcer Dey E. The role of components of bifidobacterium and lactobacillus in pathogenesis and serologic diagnosis of autoimmune thyroid diseases. BM. 2011;2(2):139\u201354. https:\/\/doi.org\/10.3920\/BM2010.0011.","journal-title":"BM"},{"key":"2462_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4607491","volume":"2017","author":"LM Rocha-Ram\u00edrez","year":"2017","unstructured":"Rocha-Ram\u00edrez LM, P\u00e9rez-Solano RA, Casta\u00f1\u00f3n-Alonso SL, Moreno Guerrero SS, Ram\u00edrez Pacheco A, Garc\u00eda Garibay M, et al. Probiotic lactobacillus strains stimulate the inflammatory response and activate human macrophages. J Immunol Res. 2017;2017:1\u201314. https:\/\/doi.org\/10.1155\/2017\/4607491.","journal-title":"J Immunol Res"},{"issue":"11","key":"2462_CR33","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.7150\/ijbs.24151","volume":"14","author":"HM Ishaq","year":"2018","unstructured":"Ishaq HM, Mohammad IS, Shahzad M, Ma C, Raza MA, Wu X, et al. Molecular alteration analysis of human gut microbial composition in graves\u2019 disease patients. Int J Biol Sci. 2018;14(11):1558\u201370. https:\/\/doi.org\/10.7150\/ijbs.24151.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2462_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/jpm10040192","volume":"10","author":"I Cornejo-Pareja","year":"2020","unstructured":"Cornejo-Pareja I, Ruiz-Lim\u00f3n P, G\u00f3mez-P\u00e9rez AM, Molina-Vega M, Moreno-Indias I, Tinahones FJ. Differential microbial pattern description in subjects with autoimmune-based thyroid diseases: a pilot study. JPM. 2020;10(4):192. https:\/\/doi.org\/10.3390\/jpm10040192.","journal-title":"JPM"},{"issue":"8","key":"2462_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40618-019-1010-9","volume":"42","author":"TT Shi","year":"2019","unstructured":"Shi TT, Xin Z, Hua L, Zhao R-X, Yang Y-L, Wang H, et al. Alterations in the intestinal microbiota of patients with severe and active graves\u2019 orbitopathy: a cross-sectional study. J Endocrinol Invest. 2019;42(8):967\u201378. https:\/\/doi.org\/10.1007\/s40618-019-1010-9.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2462_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8(1):43. https:\/\/doi.org\/10.1186\/s13073-016-0299-7.","journal-title":"Genome Med"},{"issue":"5","key":"2462_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):379\u2013401. https:\/\/doi.org\/10.1038\/s41573-019-0016-5.","journal-title":"Nat Rev Drug Discov"},{"key":"2462_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","volume":"11","author":"YS Huang","year":"2020","unstructured":"Huang YS, Ogbechi J, Clanchy FI, Williams RO, Stone TW. IDO and kynurenine metabolites in peripheral and CNS disorders. Front Immunol. 2020;11:388. https:\/\/doi.org\/10.3389\/fimmu.2020.00388.","journal-title":"Front Immunol"},{"issue":"6","key":"2462_CR39","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/cells9061564","volume":"9","author":"T Biernacki","year":"2020","unstructured":"Biernacki T, Sandi D, Bencsik K, V\u00e9csei L. Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives. Cells. 2020;9(6):1564. https:\/\/doi.org\/10.3390\/cells9061564.","journal-title":"Cells"},{"issue":"6","key":"2462_CR40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1210\/clinem\/dgad004","volume":"108","author":"HO Ueland","year":"2023","unstructured":"Ueland HO, Ulvik A, L\u00f8v\u00e5s K, Wolff ASB, Breivik LE, Stokland A-EM, et al. Systemic activation of the Kynurenine pathway in graves disease with and without ophthalmopathy. J CLIN ENDOCR Metab. 2023;108(6):1290\u201397. https:\/\/doi.org\/10.1210\/clinem\/dgad004.","journal-title":"J CLIN ENDOCR Metab"},{"issue":"1","key":"2462_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.gene.2013.07.069","volume":"531","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhu S, Xu Y, Wang X, Zhu Y. Interaction between gene A-positive Helicobacter pylori and human leukocyte antigen II alleles increase the risk of graves disease in Chinese han population: an association study. Gene. 2013, 15;531(1):84\u201389. https:\/\/doi.org\/10.1016\/j.gene.2013.07.069.","journal-title":"Gene"},{"issue":"1","key":"2462_CR42","doi-asserted-by":"publisher","first-page":"20100","DOI":"10.1038\/s41598-019-56631-4","volume":"9","author":"F Frost","year":"2019","unstructured":"Frost F, Kacprowski T, R\u00fchlemann M, Bang C, Franke A, Zimmermann K, et al. Helicobacter pylori infection associates with fecal microbiota composition and diversity. Sci Rep. 2019;9(1):20100. https:\/\/doi.org\/10.1038\/s41598-019-56631-4.","journal-title":"Sci Rep"},{"key":"2462_CR43","doi-asserted-by":"publisher","unstructured":"Dash NR, Khoder G, Nada AM, Al Bataineh MT. Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS One. 2019;14(6):e0218274. https:\/\/doi.org\/10.1371\/journal.pone.0218274.","DOI":"10.1371\/journal.pone.0218274"},{"issue":"4","key":"2462_CR44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000500634","volume":"101","author":"C Iino","year":"2020","unstructured":"Iino C, Shimoyama T, Chinda D, Sakuraba H, Fukuda S, Nakaji S. Influence of Helicobacter pylori infection and atrophic gastritis on the gut microbiota in a Japanese population. Digestion. 2020;101(4):422\u201332. https:\/\/doi.org\/10.1159\/000500634.","journal-title":"Digestion"},{"issue":"9","key":"2462_CR45","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1046\/j.1365-2036.2001.01033.x","volume":"15","author":"A B\u00fchling","year":"2001","unstructured":"B\u00fchling A, Radun D, M\u00fcller WA, Malfertheiner P. Influence of anti-helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. Aliment Pharmacol Ther. 2001;15(9):1445\u201352. https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01033.x.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02462-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:53:17Z","timestamp":1787035997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02462-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2462"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02462-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Board of The Affiliated Yan\u2019an Hospital of Kunming Medical University. Informed consent was obtained from all participants before study commencement.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"241"}}